[BioS] AbClon transfers rights to TIGIT antibody co-developed with Yuhan
Predicted impact: Low
TIGIT antibody rights transfer; deal size not disclosed.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.